Chondros Dimitrios 4
4 · HALOZYME THERAPEUTICS INC · Filed Aug 6, 2018
Insider Transaction Report
Form 4
Chondros Dimitrios
SVP, Chief Medical Officer
Transactions
- Tax Payment
Common Stock
2018-08-03$17.08/sh−1,305$22,289→ 34,102 total
Footnotes (1)
- [F1]The reported disposition of 1,305 shares represents the shares that were withheld by the issuer as payment for minimum statutory obligations due upon vesting of 3,750 restricted stock award shares.